ECSP18000069A - Sistemas de administración oral para agentes bioactivos - Google Patents

Sistemas de administración oral para agentes bioactivos

Info

Publication number
ECSP18000069A
ECSP18000069A ECIEPI201869A ECPI201800069A ECSP18000069A EC SP18000069 A ECSP18000069 A EC SP18000069A EC IEPI201869 A ECIEPI201869 A EC IEPI201869A EC PI201800069 A ECPI201800069 A EC PI201800069A EC SP18000069 A ECSP18000069 A EC SP18000069A
Authority
EC
Ecuador
Prior art keywords
oral administration
bioactive agents
administration systems
present
administration system
Prior art date
Application number
ECIEPI201869A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1509608.4A external-priority patent/GB2539006A/en
Priority claimed from NO20150715A external-priority patent/NO344096B1/en
Application filed filed Critical
Publication of ECSP18000069A publication Critical patent/ECSP18000069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención hace referencia a un alimento funcional y un sistema de administración oral para administrar macromoléculas bioactivas. El sistema de administración oral comprende alginato de etilendiamonio que es un vehículo para administrar fármacos macromoleculares. El sistema de administración oral de acuerdo con la presente invención es particularmente adecuado para usar en combinación con alimentos funcionales en peces.
ECIEPI201869A 2015-06-03 2018-01-02 Sistemas de administración oral para agentes bioactivos ECSP18000069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1509608.4A GB2539006A (en) 2015-06-03 2015-06-03 Functional feed
NO20150715A NO344096B1 (en) 2015-06-03 2015-06-03 Oral delivery system for bioactive active agents

Publications (1)

Publication Number Publication Date
ECSP18000069A true ECSP18000069A (es) 2018-10-31

Family

ID=56360457

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201869A ECSP18000069A (es) 2015-06-03 2018-01-02 Sistemas de administración oral para agentes bioactivos

Country Status (9)

Country Link
US (2) US20180147147A1 (es)
EP (2) EP3881835B1 (es)
CN (1) CN108076627B (es)
BR (1) BR112017026013B1 (es)
CA (1) CA2987932C (es)
CL (1) CL2017003077A1 (es)
EC (1) ECSP18000069A (es)
MX (1) MX385351B (es)
WO (1) WO2016195509A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018126394B4 (de) * 2018-10-23 2020-12-24 Universität Rostock Probiotika enthaltendes Depotsystem für dentale Anwendungen
KR102866023B1 (ko) * 2022-06-13 2025-09-29 부산대학교 산학협력단 산성 환경에서 프로바이오틱스를 보호하는 하이드록시아파타이트-하이드로겔 복합체 및 이를 포함하는 프로바이오틱스 전달용 조성물
CN120599695B (zh) * 2025-05-27 2025-12-26 安徽农业大学 一种鱼类摄食行为识别方法及系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935250A (en) * 1984-05-01 1990-06-19 Inverness Management Corporation Coated fish feed pellets
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US5658592A (en) * 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
SE9401738D0 (sv) * 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
FR2799196B1 (fr) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
JP4565691B2 (ja) * 2000-02-28 2010-10-20 株式会社Phg ヘパリン結合性成長因子用徐放基材、およびヘパリン結合性成長因子徐放剤
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
CN1268346C (zh) * 2003-11-19 2006-08-09 上海中科伍佰豪生物工程有限公司 生物多糖微胶囊及其制备方法和用途
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
CN101549158A (zh) 2009-05-08 2009-10-07 南开大学 一种海藻酸钠肝靶向纳米给药系统及其制备方法
JP2013534134A (ja) 2010-08-03 2013-09-02 ジョーロックス ピーティワイ リミテッド 補助食品を食物製品に含有させるための真空注入
UA103834C2 (ru) * 2012-06-15 2013-11-25 Павел Петрович Пивоваров Капсулированный белоксодержащий продукт и способ его получения
CN103627010A (zh) * 2013-11-18 2014-03-12 戴建英 一种海藻酸酰胺类医用敷料的制备方法

Also Published As

Publication number Publication date
CA2987932C (en) 2024-01-16
EP3881835A1 (en) 2021-09-22
BR112017026013B1 (pt) 2023-12-05
BR112017026013A2 (pt) 2018-08-14
US20180147147A1 (en) 2018-05-31
CA2987932A1 (en) 2016-12-08
CN108076627A (zh) 2018-05-25
MX385351B (es) 2025-03-18
US11844863B2 (en) 2023-12-19
US20220409541A1 (en) 2022-12-29
WO2016195509A1 (en) 2016-12-08
CN108076627B (zh) 2021-05-25
EP3881835B1 (en) 2026-04-01
MX2017015545A (es) 2018-11-09
EP3302445A1 (en) 2018-04-11
CL2017003077A1 (es) 2019-07-19

Similar Documents

Publication Publication Date Title
CY1123571T1 (el) Βουπροπιονη για τη ρυθμιση των φαρμακευτικων επιπεδων δεξτρομεθορφανης στο πλασμα
MX2022004374A (es) Composiciones de agonista de tlr9 e inhibidores de punto de control para usarse en la respuesta inmune contra el cancer.
BR112018010671A8 (pt) dispositivos e métodos de distribuição de fármaco com mudança de forma
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
BR112018002342A2 (pt) polímeros furtivos intrinsecamente desordenados e geneticamente modificados para entrega e métodos para uso dos mesmos
MX2017005236A (es) Profarmacos de carbidopa y l-dopa y metodos de uso.
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
EP3445416A4 (en) ENTERALES ACTIVE COMPOSITION SYSTEM
BR112017006957A2 (pt) formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína
BR112016016290A2 (pt) Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina
BR112015021002B8 (pt) Forma de dosagem sólida farmacêutica compreendendo um ingrediente farmacêutico ativo
BR112012019549A2 (pt) reservatório para uso em um módulo medicamentoso, módulo medicamentoso que compreende esse reservatório e dispositivo de entrega de fármaco.
CL2017000664A1 (es) Micropartículas inyectables para la liberación hiper-localizada de agentes terapéuticos
BR112015024271A2 (pt) sistema de fornecimento transdérmico
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
ECSP18000069A (es) Sistemas de administración oral para agentes bioactivos
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
BR112017002796A2 (pt) método de induzir saciedade
BR112014021497A2 (pt) sistema de entrega de fármaco baseado em jcv-vlp
BR112017024732A2 (pt) combinação farmacêutica de everolimus com dactolisibe
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
EA201691964A1 (ru) Конъюгаты для доставки лекарственного средства для лечения устойчивой формы рака и для применения в комбинированной терапии
BR112016020984A2 (pt) Aptâmero para fgf2 e uso do mesmo
BR112016007237A2 (pt) método para a profilaxia ou tratamento do lúpus eritematoso sistêmico e/ou nefrite lúpica